Back

Efficacy and safety of SGLT2 inhibitors in heart failure: observational evidence in geriatric patients AGING-HF

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Frailty, ageing and functional decline in heart failure Comorbidities Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Abdelhakim Hacil

Hospital Broca of Paris, Paris (France)

6 More presentations in this session

Presentation thumbnail
Palliative care in heart failure - do we know when to refer?
Doctor N. Melarkey (Newry, GB)
Abstract Slides Video
Presentation thumbnail
Holistic patient-centred intervention to improve outcomes of older people living with FraIlTy and heart failure (FIT-HF): feasibility study
Ms S. Krishnan (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Palliative status and short-term outcomes in very elderly patients with heart failure
Doctor R. Esser (Versailles, FR)
Abstract Slides Video
Presentation thumbnail
Real-world treatments and outcomes in very old patients with heart failure with preserved ejection fraction
Mr A. Hacil (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Multidimensional assessment of frailty in older patients with chronic heart failure: data from the TWENTE-HF study
Mrs A. Kleberger (Almelo, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Frailty, ageing and functional decline in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in heart failure: real-world evidence in geriatric patients
thumbnail
Congress Presentation
Real-world treatments and outcomes in very old patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Sodium-glucose co-transporter-2 inhibitors: prognostic benefit in real-world, elderly, comorbid HFmrEF and HFpEF patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources